CYP7A1 | Cytochrome P450, family 7, subfamily A, polypeptide 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
KLKB1 | Kallikrein B, plasma (Fletcher factor) 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LECT2 | Leukocyte cell-derived chemotaxin 2 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SDS | Serine dehydratase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
VTN | Vitronectin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CPN1 | Carboxypeptidase N, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
PLGLB1 | Plasminogen-like B1 | Predicted secreted proteins
| | | | | Tissue enriched |
RTP3 | Receptor (chemosensory) transporter protein 3 | Predicted membrane proteins
| | | | | Tissue enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP26A1 | Cytochrome P450, family 26, subfamily A, polypeptide 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CPB2 | Carboxypeptidase B2 (plasma) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
GOLGA6B | Golgin A6 family, member B | Predicted intracellular proteins
| | | | | Group enriched |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
PROZ | Protein Z, vitamin K-dependent plasma glycoprotein | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DIO1 | Deiodinase, iodothyronine, type I | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
HSD17B13 | Hydroxysteroid (17-beta) dehydrogenase 13 | Predicted intracellular proteins
| | | | | Tissue enriched |
FMO3 | Flavin containing monooxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PGLYRP2 | Peptidoglycan recognition protein 2 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
AGXT2 | Alanine--glyoxylate aminotransferase 2 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Group enriched |
AMBP | Alpha-1-microglobulin/bikunin precursor | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ANG | Angiogenin, ribonuclease, RNase A family, 5 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DPYS | Dihydropyrimidinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
UPB1 | Ureidopropionase, beta | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
UGT1A4 | UDP glucuronosyltransferase 1 family, polypeptide A4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C5 | Complement component 5 | Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
MTTP | Microsomal triglyceride transfer protein | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
ASGR1 | Asialoglycoprotein receptor 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
C4BPB | Complement component 4 binding protein, beta | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CYP2B6 | Cytochrome P450, family 2, subfamily B, polypeptide 6 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LIPC | Lipase, hepatic | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
ACOT12 | Acyl-CoA thioesterase 12 | Enzymes Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
CYP8B1 | Cytochrome P450, family 8, subfamily B, polypeptide 1 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
GYS2 | Glycogen synthase 2 (liver) | Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |